GO (Fig. 6C) and GESA analysis (Additional file 1: Fig. S5) revealed that ZC3H12C was involved in immune response in CRC, including adaptive immune response, interferon-gamma production, immune response-regulating signaling pathway, B cell activation, T cell activation. This evidence concerns the gene ZC3H12C and colorectal carcinoma.